TrademarkDir
RETHINK ADHD SYMPTOM CONTROL
LIVE

Serial Number

90287870

Owner

SUPERNUS PHARMACEUTICALS, INC.

Attorney

Mark Simpson

First Use Date

May 25, 2021

Filing Date

Oct 29, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RETHINK ADHD SYMPTOM CONTROL Trademark

Serial Number: 90287870 • Registration: 6668162

RETHINK ADHD SYMPTOM CONTROL is a trademark filed by SUPERNUS PHARMACEUTICALS, INC. on October 29, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SUPERNUS PHARMACEUTICALS, INC. (49 trademarks)

1550 EAST GUDE DRIVE
ROCKVILLE, MD 20850

Entity Type: 03

Trademark Details

Filing Date

October 29, 2020

Registration Date

March 8, 2022

First Use Anywhere

May 25, 2021

First Use in Commerce

July 19, 2021

Published for Opposition

May 18, 2021

Goods & Services

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Filing History

REGISTERED-PRINCIPAL REGISTER
Mar 8, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 3, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 2, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 31, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 28, 2022 AITU
USE AMENDMENT FILED
Jan 13, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 13, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 13, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 18, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 18, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 28, 2021 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 13, 2021 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2021 CNSA
ASSIGNED TO EXAMINER
Mar 30, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2020 NWOS
NEW APPLICATION ENTERED
Nov 2, 2020 NWAP

Related Trademarks

More from this Owner

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG logo

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG logo

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES logo

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES logo

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG logo

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG logo

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG